Skip to main content
. 2021 May 31;12:20406207211018042. doi: 10.1177/20406207211018042

Table 4.

Adverse reactions for 510 mg and 1020 mg ferumoxytol infusions.

Subject Symptom
510 mg 1 Flushing and chest pain (infusion stopped) then restarted and completed; flushing, SOB (infusion stopped and then completed)
2 Abdominal pain, headache, flush, chest tightness
3 Nasal congestion 10 min after ferumoxytol
4 Lightheadedness
5 Chest pressure, SOB, flushing, back pain
6 SOB and chest pressure
7 Flushing, chest pressure; resolved with fluids
8 Chest tightness
9 Nausea and nasal congestion
10 Facial itching
11 Flushing and nausea
1020 mg 1 Lightheadedness
2 Flushing, infusion stopped, restarted at slower rate; completed without further difficulty
3 Tightness in chest and SOB
4 Fatigue
5 Flushing, nausea after ranitidine and methylprednisolone
6 Facial flushing; subsided when infusion stopped
7 Cough, scratchy throat
8 Cough

Adverse reactions for 510 mg: n = 11; 1020 mg: n = 8.

SOB, shortness of breath.